Cargando…
No common denominator for breast cancer lymph node metastasis
The axillary lymph node status is the most powerful prognostic factor for breast cancer patients to date. The molecular mechanisms that control lymph node metastasis, however, remain poorly understood. To define patterns of genes or gene regulatory pathways that drive breast cancer lymph node metast...
Autores principales: | Weigelt, B, Wessels, L F A, Bosma, A J, Glas, A M, Nuyten, D S A, He, Y D, Dai, H, Peterse, J L, van't Veer, L J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361648/ https://www.ncbi.nlm.nih.gov/pubmed/16189523 http://dx.doi.org/10.1038/sj.bjc.6602794 |
Ejemplares similares
-
Lymph node metastases display gene expression profiles of their primary breast carcinomas
por: Weigelt, B, et al.
Publicado: (2005) -
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004) -
High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer
por: Lee, H E, et al.
Publicado: (2011) -
Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics
por: Wang, W, et al.
Publicado: (2014) -
A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
por: Molloy, T J, et al.
Publicado: (2011)